A Phase II Study of Radscopal Radiotherapy Combined with Immunotherapy as First-Line Treatment for Chemotherapy-Ineligible Patients with De Novo Metastatic Nasopharyngeal Carcinoma (RADIANCE)

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 858d8b66cf9c472f74ad01fe3f4c5ab4822bef18
First added on: Oct 10, 2026